Collaboration will unlock our potential and define our success.
The impact of an FDA "Listening Session" on gene therapy for hemophilia.
NHF maintains its prestigious 4-star rating from Charity Navigator, the largest independent charity evaluator in the US.
The organizations continue to monitor the outbreak.
The summit was convened to address recent issues regarding recalls and product safety.
The Green Park Collaborative and the National Hemophilia Foundation launch project to develop a PROM to measure mental health outlook.
Nationally recognized researcher Dr. Leonard Valentino to lead the Foundation into the future.
Groups argue patients need a quick resolution to ensure access to care.
The appointment is effective as of December 5, 2019.
HFA and NHF have responded to our community’s needs and assembled a Safety Summit to be held in January of 2020.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car